Creating a blood test to detect neurodegenerative diseases like Alzheimer's
Official title: Development of a blood-based test for neurodegenerative diseases
Funded at 3d Bioanalytix, INC. · NIH-10922630 · Data updated 2026-11-12
This study is working on a new blood test that can help doctors spot Alzheimer's and other brain diseases earlier by looking for specific proteins that are out of shape, making it easier to get the right treatment for you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | 3d Bioanalytix, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | September 25, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $472,695 |
| NIH project number | 1R41AG087866-01 |
| Project ID | NIH-10922630 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing early signs of cognitive decline or those at risk for neurodegenerative diseases.
✕Less likely to help
Patients who are not experiencing cognitive issues or who have already been diagnosed with advanced neurodegenerative diseases may not benefit from this research.
What this research studies
This research aims to develop a blood-based diagnostic test that can identify and differentiate neurodegenerative diseases, particularly Alzheimer's disease. By utilizing a novel technology called Covalent Protein Painting, the researchers will analyze misfolded protein aggregates that are characteristic of these conditions. This approach seeks to provide an early detection method, which is currently lacking, and could help physicians make more accurate diagnoses and tailor treatments accordingly.
Why it matters
Potential benefit: If successful, this research could lead to a reliable blood test that allows for earlier and more accurate diagnosis of neurodegenerative diseases.
How similar studies have gone: While the approach of using blood tests for neurodegenerative disease detection is gaining interest, this specific method using Covalent Protein Painting is relatively novel and has not been widely tested.
Where this research is happening
-
3d Bioanalytix, INC.
San Diego, United States Active
Researchers
- Principal investigator: Pankow, Sandra — 3d Bioanalytix, INC.
- Study coordinator: Pankow, Sandra
Related research
Other NIH-funded projects on the same topics.
-
Developing small molecules to treat TDP-43 related brain diseases
A potential new drug candidate (XL20) for diseases like Alzheimer’s and other dementias linked to TDP-43 protein problems is being developed and refined for people who live with these conditions.
-
Tau filament structure in Alzheimer’s and related dementias
Aims to map the detailed 3D shapes of tau protein filaments found in human brain diseases to help develop better diagnostics and treatments for Alzheimer’s-related dementias.
-
Targeting RNA Splicing Abnormalities in ALS/FTD
A research team aims to understand and correct abnormal RNA splicing in ALS and related brain diseases to help patients in the future.
-
Blood-brain barrier–friendly imaging agents for neurodegenerative diseases
A researcher team will test new imaging agents that can cross the brain barrier to help detect Alzheimer’s and related diseases earlier and more accurately.
-
Brain cell–derived EV markers to differentiate Alzheimer’s and related dementias
A Mayo Clinic team is testing brain-cell–specific tiny particles in blood to tell apart Alzheimer’s disease and similar dementias using advanced machine-learning analysis.
-
Fisetin approach to reduce vulnerability to community infections in aging veterans
A patient-friendly look at a study testing whether the natural compound fisetin can help aging Veterans stay healthier when they face common infections.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.